Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 GILD | Gilead Sciences Inc | $169.2b | $139.71 | -0.5% | 3.8M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $114.98 | +0.1% | 588.9K |
 NTLA | Intellia Therapeutics, Inc | $1.4b | $14.93 | +1.0% | 2.7M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.83 | +5.2% | 12.2M |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $10.99 | +0.4% | 322.2K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $3.44 | -1.1% | 4.3M |
 VOR | Vor Biopharma Inc. Common Stock | $0.6b | $15.60 | -1.7% | 881.9K |
 YDES | YD Bio Limited Ordinary Shares | $0.6b | $5.30 | -7.0% | 31.6K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $2.17 | -4.8% | 74.0M |
 IMMX | Immix Biopharma, Inc. Common Stock | $454.4m | $10.06 | +2.1% | 617.0K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $449.6m | $23.86 | +2.1% | 87.0K |
 ENGN | enGene Holdings Inc. Common Stock | $414.0m | $7.74 | +1.8% | 211.3K |
 IPSC | Century Therapeutics, Inc. Common Stock | $364.8m | $2.60 | +9.9% | 1.6M |
 CRBU | Caribou Biosciences, Inc. Common Stock | $166.2m | $2.19 | +3.5% | 2.0M |
 NKTX | Nkarta, Inc. Common Stock | $142.6m | $2.42 | +5.5% | 756.1K |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $134.7m | $9.13 | +21.9% | 876.7K |
 FATE | Fate Therapeutics, Inc. | $131.4m | $1.29 | -3.7% | 1.4M |
 ANIX | Anixa Biosciences, Inc. | $83.8m | $2.90 | +0.9% | 93.1K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $12.84 | +3.2% | 19.2K |
 ACET | Adicet Bio, Inc. Common Stock | $58.6m | $7.90 | +12.9% | 345.7K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $53.5m | $1.06 | +0.5% | 987.1K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $49.4m | $12.96 | -4.0% | 62.2K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $43.9m | $1.75 | +2.6% | 72.1K |
 CELU | Celularity Inc. Class A Common Stock | $36.3m | $1.28 | -1.1% | 5.8K |
 ATRA | Atara Biotherapeutics, Inc | $35.3m | $5.25 | +1.9% | 53.5K |
 SNTI | Senti Biosciences, Inc. Common Stock | $24.0m | $0.95 | +2.0% | 169.3K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $17.4m | $6.28 | +5.0% | 20.0K |
 INAB | IN8bio, Inc. Common Stock | $13.5m | $1.40 | +1.4% | 58.6K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $12.1m | $1.00 | -0.0% | 5.6K |
 LNAI | Lunai Bioworks Inc. Common Stock | $10.0m | $0.32 | -5.6% | 27.8M |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $7.2m | $0.77 | +12.3% | 358.3K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $5.5m | $0.19 | -6.1% | 1.5M |
 MBIO | Mustang Bio, Inc. | $5.5m | $0.77 | +2.7% | 35.4K |
 CLDI | Calidi Biotherapeutics, Inc. | $2.3m | $0.27 | -0.0% | 5.4M |